Kodiak Sciences Inc. (KOD) is a biotechnology company that develops transformative therapies for retinal diseases. Through their innovation in drug discovery, Kodiak aims to address unmet medical needs and improve the lives of patients suffering from conditions such as age-related macular degeneration and diabetic retinopathy. With a focus on precision medicine, Kodiak is revolutionizing the treatment landscape in ophthalmology.
